EDQM Certificate of Suitability granted – May, 2006

Bovogen Biologicals received a Certificate of Suitability from the European Directorate of Quality Medicines for it's range of bovine serum albumin products in May, 2006. This certification meets the criteria described in the current version of the monograph "Products with Risk of Transmitting Agents of Animal Spongiform Encephalopathies No. 1483 of the European Pharmacopoeia.

This Certificate of Suitability also covers some of the components used in the manufacture of at least one type of BSA product manufactured by Bovogen Biologicals.